Medical Care

Global Anti-CD47 Antibody Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Anti-CD47 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-CD47 Antibody.
The Anti-CD47 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-CD47 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-CD47 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BosterBio
Leinco Technologies
Bioss
Novus Biologicals
Thermo Fisher Scientific
Biorbyt
Abbexa
Bio X Cell
GeneTex
R&D Systems
LSBio
MyBioSource
ProSci
antibodies-online
ABclonal Technology
Abnova Corporation
G Biosciences
BioLegend
Bio-Rad
Huabio
BPS Bioscience
OriGene Technologies
St John's Laboratory
Absolute Antibody
NSJ Bioreagents
Cell Signaling Technology
RayBiotech
Beijing Solarbio Science & Technology
Bethyl Laboratories
Abeomics
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-CD47 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-CD47 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Anti-CD47 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-CD47 Antibody Market Perspective (2020-2031)
2.2 Global Anti-CD47 Antibody Growth Trends by Region
2.2.1 Global Anti-CD47 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-CD47 Antibody Historic Market Size by Region (2020-2025)
2.2.3 Anti-CD47 Antibody Forecasted Market Size by Region (2026-2031)
2.3 Anti-CD47 Antibody Market Dynamics
2.3.1 Anti-CD47 Antibody Industry Trends
2.3.2 Anti-CD47 Antibody Market Drivers
2.3.3 Anti-CD47 Antibody Market Challenges
2.3.4 Anti-CD47 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-CD47 Antibody Players by Revenue
3.1.1 Global Top Anti-CD47 Antibody Players by Revenue (2020-2025)
3.1.2 Global Anti-CD47 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Anti-CD47 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-CD47 Antibody Revenue
3.4 Global Anti-CD47 Antibody Market Concentration Ratio
3.4.1 Global Anti-CD47 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-CD47 Antibody Revenue in 2024
3.5 Global Key Players of Anti-CD47 Antibody Head office and Area Served
3.6 Global Key Players of Anti-CD47 Antibody, Product and Application
3.7 Global Key Players of Anti-CD47 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-CD47 Antibody Breakdown Data by Type
4.1 Global Anti-CD47 Antibody Historic Market Size by Type (2020-2025)
4.2 Global Anti-CD47 Antibody Forecasted Market Size by Type (2026-2031)
5 Anti-CD47 Antibody Breakdown Data by Application
5.1 Global Anti-CD47 Antibody Historic Market Size by Application (2020-2025)
5.2 Global Anti-CD47 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-CD47 Antibody Market Size (2020-2031)
6.2 North America Anti-CD47 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-CD47 Antibody Market Size by Country (2020-2025)
6.4 North America Anti-CD47 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-CD47 Antibody Market Size (2020-2031)
7.2 Europe Anti-CD47 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-CD47 Antibody Market Size by Country (2020-2025)
7.4 Europe Anti-CD47 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-CD47 Antibody Market Size (2020-2031)
8.2 Asia-Pacific Anti-CD47 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-CD47 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-CD47 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-CD47 Antibody Market Size (2020-2031)
9.2 Latin America Anti-CD47 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-CD47 Antibody Market Size by Country (2020-2025)
9.4 Latin America Anti-CD47 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-CD47 Antibody Market Size (2020-2031)
10.2 Middle East & Africa Anti-CD47 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-CD47 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-CD47 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BosterBio
11.1.1 BosterBio Company Details
11.1.2 BosterBio Business Overview
11.1.3 BosterBio Anti-CD47 Antibody Introduction
11.1.4 BosterBio Revenue in Anti-CD47 Antibody Business (2020-2025)
11.1.5 BosterBio Recent Development
11.2 Leinco Technologies
11.2.1 Leinco Technologies Company Details
11.2.2 Leinco Technologies Business Overview
11.2.3 Leinco Technologies Anti-CD47 Antibody Introduction
11.2.4 Leinco Technologies Revenue in Anti-CD47 Antibody Business (2020-2025)
11.2.5 Leinco Technologies Recent Development
11.3 Bioss
11.3.1 Bioss Company Details
11.3.2 Bioss Business Overview
11.3.3 Bioss Anti-CD47 Antibody Introduction
11.3.4 Bioss Revenue in Anti-CD47 Antibody Business (2020-2025)
11.3.5 Bioss Recent Development
11.4 Novus Biologicals
11.4.1 Novus Biologicals Company Details
11.4.2 Novus Biologicals Business Overview
11.4.3 Novus Biologicals Anti-CD47 Antibody Introduction
11.4.4 Novus Biologicals Revenue in Anti-CD47 Antibody Business (2020-2025)
11.4.5 Novus Biologicals Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Anti-CD47 Antibody Introduction
11.5.4 Thermo Fisher Scientific Revenue in Anti-CD47 Antibody Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Biorbyt
11.6.1 Biorbyt Company Details
11.6.2 Biorbyt Business Overview
11.6.3 Biorbyt Anti-CD47 Antibody Introduction
11.6.4 Biorbyt Revenue in Anti-CD47 Antibody Business (2020-2025)
11.6.5 Biorbyt Recent Development
11.7 Abbexa
11.7.1 Abbexa Company Details
11.7.2 Abbexa Business Overview
11.7.3 Abbexa Anti-CD47 Antibody Introduction
11.7.4 Abbexa Revenue in Anti-CD47 Antibody Business (2020-2025)
11.7.5 Abbexa Recent Development
11.8 Bio X Cell
11.8.1 Bio X Cell Company Details
11.8.2 Bio X Cell Business Overview
11.8.3 Bio X Cell Anti-CD47 Antibody Introduction
11.8.4 Bio X Cell Revenue in Anti-CD47 Antibody Business (2020-2025)
11.8.5 Bio X Cell Recent Development
11.9 GeneTex
11.9.1 GeneTex Company Details
11.9.2 GeneTex Business Overview
11.9.3 GeneTex Anti-CD47 Antibody Introduction
11.9.4 GeneTex Revenue in Anti-CD47 Antibody Business (2020-2025)
11.9.5 GeneTex Recent Development
11.10 R&D Systems
11.10.1 R&D Systems Company Details
11.10.2 R&D Systems Business Overview
11.10.3 R&D Systems Anti-CD47 Antibody Introduction
11.10.4 R&D Systems Revenue in Anti-CD47 Antibody Business (2020-2025)
11.10.5 R&D Systems Recent Development
11.11 LSBio
11.11.1 LSBio Company Details
11.11.2 LSBio Business Overview
11.11.3 LSBio Anti-CD47 Antibody Introduction
11.11.4 LSBio Revenue in Anti-CD47 Antibody Business (2020-2025)
11.11.5 LSBio Recent Development
11.12 MyBioSource
11.12.1 MyBioSource Company Details
11.12.2 MyBioSource Business Overview
11.12.3 MyBioSource Anti-CD47 Antibody Introduction
11.12.4 MyBioSource Revenue in Anti-CD47 Antibody Business (2020-2025)
11.12.5 MyBioSource Recent Development
11.13 ProSci
11.13.1 ProSci Company Details
11.13.2 ProSci Business Overview
11.13.3 ProSci Anti-CD47 Antibody Introduction
11.13.4 ProSci Revenue in Anti-CD47 Antibody Business (2020-2025)
11.13.5 ProSci Recent Development
11.14 antibodies-online
11.14.1 antibodies-online Company Details
11.14.2 antibodies-online Business Overview
11.14.3 antibodies-online Anti-CD47 Antibody Introduction
11.14.4 antibodies-online Revenue in Anti-CD47 Antibody Business (2020-2025)
11.14.5 antibodies-online Recent Development
11.15 ABclonal Technology
11.15.1 ABclonal Technology Company Details
11.15.2 ABclonal Technology Business Overview
11.15.3 ABclonal Technology Anti-CD47 Antibody Introduction
11.15.4 ABclonal Technology Revenue in Anti-CD47 Antibody Business (2020-2025)
11.15.5 ABclonal Technology Recent Development
11.16 Abnova Corporation
11.16.1 Abnova Corporation Company Details
11.16.2 Abnova Corporation Business Overview
11.16.3 Abnova Corporation Anti-CD47 Antibody Introduction
11.16.4 Abnova Corporation Revenue in Anti-CD47 Antibody Business (2020-2025)
11.16.5 Abnova Corporation Recent Development
11.17 G Biosciences
11.17.1 G Biosciences Company Details
11.17.2 G Biosciences Business Overview
11.17.3 G Biosciences Anti-CD47 Antibody Introduction
11.17.4 G Biosciences Revenue in Anti-CD47 Antibody Business (2020-2025)
11.17.5 G Biosciences Recent Development
11.18 BioLegend
11.18.1 BioLegend Company Details
11.18.2 BioLegend Business Overview
11.18.3 BioLegend Anti-CD47 Antibody Introduction
11.18.4 BioLegend Revenue in Anti-CD47 Antibody Business (2020-2025)
11.18.5 BioLegend Recent Development
11.19 Bio-Rad
11.19.1 Bio-Rad Company Details
11.19.2 Bio-Rad Business Overview
11.19.3 Bio-Rad Anti-CD47 Antibody Introduction
11.19.4 Bio-Rad Revenue in Anti-CD47 Antibody Business (2020-2025)
11.19.5 Bio-Rad Recent Development
11.20 Huabio
11.20.1 Huabio Company Details
11.20.2 Huabio Business Overview
11.20.3 Huabio Anti-CD47 Antibody Introduction
11.20.4 Huabio Revenue in Anti-CD47 Antibody Business (2020-2025)
11.20.5 Huabio Recent Development
11.21 BPS Bioscience
11.21.1 BPS Bioscience Company Details
11.21.2 BPS Bioscience Business Overview
11.21.3 BPS Bioscience Anti-CD47 Antibody Introduction
11.21.4 BPS Bioscience Revenue in Anti-CD47 Antibody Business (2020-2025)
11.21.5 BPS Bioscience Recent Development
11.22 OriGene Technologies
11.22.1 OriGene Technologies Company Details
11.22.2 OriGene Technologies Business Overview
11.22.3 OriGene Technologies Anti-CD47 Antibody Introduction
11.22.4 OriGene Technologies Revenue in Anti-CD47 Antibody Business (2020-2025)
11.22.5 OriGene Technologies Recent Development
11.23 St John's Laboratory
11.23.1 St John's Laboratory Company Details
11.23.2 St John's Laboratory Business Overview
11.23.3 St John's Laboratory Anti-CD47 Antibody Introduction
11.23.4 St John's Laboratory Revenue in Anti-CD47 Antibody Business (2020-2025)
11.23.5 St John's Laboratory Recent Development
11.24 Absolute Antibody
11.24.1 Absolute Antibody Company Details
11.24.2 Absolute Antibody Business Overview
11.24.3 Absolute Antibody Anti-CD47 Antibody Introduction
11.24.4 Absolute Antibody Revenue in Anti-CD47 Antibody Business (2020-2025)
11.24.5 Absolute Antibody Recent Development
11.25 NSJ Bioreagents
11.25.1 NSJ Bioreagents Company Details
11.25.2 NSJ Bioreagents Business Overview
11.25.3 NSJ Bioreagents Anti-CD47 Antibody Introduction
11.25.4 NSJ Bioreagents Revenue in Anti-CD47 Antibody Business (2020-2025)
11.25.5 NSJ Bioreagents Recent Development
11.26 Cell Signaling Technology
11.26.1 Cell Signaling Technology Company Details
11.26.2 Cell Signaling Technology Business Overview
11.26.3 Cell Signaling Technology Anti-CD47 Antibody Introduction
11.26.4 Cell Signaling Technology Revenue in Anti-CD47 Antibody Business (2020-2025)
11.26.5 Cell Signaling Technology Recent Development
11.27 RayBiotech
11.27.1 RayBiotech Company Details
11.27.2 RayBiotech Business Overview
11.27.3 RayBiotech Anti-CD47 Antibody Introduction
11.27.4 RayBiotech Revenue in Anti-CD47 Antibody Business (2020-2025)
11.27.5 RayBiotech Recent Development
11.28 Beijing Solarbio Science & Technology
11.28.1 Beijing Solarbio Science & Technology Company Details
11.28.2 Beijing Solarbio Science & Technology Business Overview
11.28.3 Beijing Solarbio Science & Technology Anti-CD47 Antibody Introduction
11.28.4 Beijing Solarbio Science & Technology Revenue in Anti-CD47 Antibody Business (2020-2025)
11.28.5 Beijing Solarbio Science & Technology Recent Development
11.29 Bethyl Laboratories
11.29.1 Bethyl Laboratories Company Details
11.29.2 Bethyl Laboratories Business Overview
11.29.3 Bethyl Laboratories Anti-CD47 Antibody Introduction
11.29.4 Bethyl Laboratories Revenue in Anti-CD47 Antibody Business (2020-2025)
11.29.5 Bethyl Laboratories Recent Development
11.30 Abeomics
11.30.1 Abeomics Company Details
11.30.2 Abeomics Business Overview
11.30.3 Abeomics Anti-CD47 Antibody Introduction
11.30.4 Abeomics Revenue in Anti-CD47 Antibody Business (2020-2025)
11.30.5 Abeomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-CD47 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global Anti-CD47 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Anti-CD47 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti-CD47 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Anti-CD47 Antibody Market Share by Region (2020-2025)
Table 8. Global Anti-CD47 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Anti-CD47 Antibody Market Share by Region (2026-2031)
Table 10. Anti-CD47 Antibody Market Trends
Table 11. Anti-CD47 Antibody Market Drivers
Table 12. Anti-CD47 Antibody Market Challenges
Table 13. Anti-CD47 Antibody Market Restraints
Table 14. Global Anti-CD47 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Anti-CD47 Antibody Market Share by Players (2020-2025)
Table 16. Global Top Anti-CD47 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD47 Antibody as of 2024)
Table 17. Ranking of Global Top Anti-CD47 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti-CD47 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Anti-CD47 Antibody, Headquarters and Area Served
Table 20. Global Key Players of Anti-CD47 Antibody, Product and Application
Table 21. Global Key Players of Anti-CD47 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-CD47 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Anti-CD47 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global Anti-CD47 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-CD47 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global Anti-CD47 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Anti-CD47 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global Anti-CD47 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Anti-CD47 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America Anti-CD47 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Anti-CD47 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Anti-CD47 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Anti-CD47 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Anti-CD47 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Anti-CD47 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Anti-CD47 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Anti-CD47 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Anti-CD47 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-CD47 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Anti-CD47 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Anti-CD47 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Anti-CD47 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Anti-CD47 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Anti-CD47 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. BosterBio Company Details
Table 47. BosterBio Business Overview
Table 48. BosterBio Anti-CD47 Antibody Product
Table 49. BosterBio Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 50. BosterBio Recent Development
Table 51. Leinco Technologies Company Details
Table 52. Leinco Technologies Business Overview
Table 53. Leinco Technologies Anti-CD47 Antibody Product
Table 54. Leinco Technologies Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 55. Leinco Technologies Recent Development
Table 56. Bioss Company Details
Table 57. Bioss Business Overview
Table 58. Bioss Anti-CD47 Antibody Product
Table 59. Bioss Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 60. Bioss Recent Development
Table 61. Novus Biologicals Company Details
Table 62. Novus Biologicals Business Overview
Table 63. Novus Biologicals Anti-CD47 Antibody Product
Table 64. Novus Biologicals Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 65. Novus Biologicals Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Anti-CD47 Antibody Product
Table 69. Thermo Fisher Scientific Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Biorbyt Company Details
Table 72. Biorbyt Business Overview
Table 73. Biorbyt Anti-CD47 Antibody Product
Table 74. Biorbyt Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 75. Biorbyt Recent Development
Table 76. Abbexa Company Details
Table 77. Abbexa Business Overview
Table 78. Abbexa Anti-CD47 Antibody Product
Table 79. Abbexa Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 80. Abbexa Recent Development
Table 81. Bio X Cell Company Details
Table 82. Bio X Cell Business Overview
Table 83. Bio X Cell Anti-CD47 Antibody Product
Table 84. Bio X Cell Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 85. Bio X Cell Recent Development
Table 86. GeneTex Company Details
Table 87. GeneTex Business Overview
Table 88. GeneTex Anti-CD47 Antibody Product
Table 89. GeneTex Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 90. GeneTex Recent Development
Table 91. R&D Systems Company Details
Table 92. R&D Systems Business Overview
Table 93. R&D Systems Anti-CD47 Antibody Product
Table 94. R&D Systems Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 95. R&D Systems Recent Development
Table 96. LSBio Company Details
Table 97. LSBio Business Overview
Table 98. LSBio Anti-CD47 Antibody Product
Table 99. LSBio Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 100. LSBio Recent Development
Table 101. MyBioSource Company Details
Table 102. MyBioSource Business Overview
Table 103. MyBioSource Anti-CD47 Antibody Product
Table 104. MyBioSource Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 105. MyBioSource Recent Development
Table 106. ProSci Company Details
Table 107. ProSci Business Overview
Table 108. ProSci Anti-CD47 Antibody Product
Table 109. ProSci Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 110. ProSci Recent Development
Table 111. antibodies-online Company Details
Table 112. antibodies-online Business Overview
Table 113. antibodies-online Anti-CD47 Antibody Product
Table 114. antibodies-online Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 115. antibodies-online Recent Development
Table 116. ABclonal Technology Company Details
Table 117. ABclonal Technology Business Overview
Table 118. ABclonal Technology Anti-CD47 Antibody Product
Table 119. ABclonal Technology Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 120. ABclonal Technology Recent Development
Table 121. Abnova Corporation Company Details
Table 122. Abnova Corporation Business Overview
Table 123. Abnova Corporation Anti-CD47 Antibody Product
Table 124. Abnova Corporation Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 125. Abnova Corporation Recent Development
Table 126. G Biosciences Company Details
Table 127. G Biosciences Business Overview
Table 128. G Biosciences Anti-CD47 Antibody Product
Table 129. G Biosciences Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 130. G Biosciences Recent Development
Table 131. BioLegend Company Details
Table 132. BioLegend Business Overview
Table 133. BioLegend Anti-CD47 Antibody Product
Table 134. BioLegend Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 135. BioLegend Recent Development
Table 136. Bio-Rad Company Details
Table 137. Bio-Rad Business Overview
Table 138. Bio-Rad Anti-CD47 Antibody Product
Table 139. Bio-Rad Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 140. Bio-Rad Recent Development
Table 141. Huabio Company Details
Table 142. Huabio Business Overview
Table 143. Huabio Anti-CD47 Antibody Product
Table 144. Huabio Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 145. Huabio Recent Development
Table 146. BPS Bioscience Company Details
Table 147. BPS Bioscience Business Overview
Table 148. BPS Bioscience Anti-CD47 Antibody Product
Table 149. BPS Bioscience Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 150. BPS Bioscience Recent Development
Table 151. OriGene Technologies Company Details
Table 152. OriGene Technologies Business Overview
Table 153. OriGene Technologies Anti-CD47 Antibody Product
Table 154. OriGene Technologies Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 155. OriGene Technologies Recent Development
Table 156. St John's Laboratory Company Details
Table 157. St John's Laboratory Business Overview
Table 158. St John's Laboratory Anti-CD47 Antibody Product
Table 159. St John's Laboratory Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 160. St John's Laboratory Recent Development
Table 161. Absolute Antibody Company Details
Table 162. Absolute Antibody Business Overview
Table 163. Absolute Antibody Anti-CD47 Antibody Product
Table 164. Absolute Antibody Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 165. Absolute Antibody Recent Development
Table 166. NSJ Bioreagents Company Details
Table 167. NSJ Bioreagents Business Overview
Table 168. NSJ Bioreagents Anti-CD47 Antibody Product
Table 169. NSJ Bioreagents Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 170. NSJ Bioreagents Recent Development
Table 171. Cell Signaling Technology Company Details
Table 172. Cell Signaling Technology Business Overview
Table 173. Cell Signaling Technology Anti-CD47 Antibody Product
Table 174. Cell Signaling Technology Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 175. Cell Signaling Technology Recent Development
Table 176. RayBiotech Company Details
Table 177. RayBiotech Business Overview
Table 178. RayBiotech Anti-CD47 Antibody Product
Table 179. RayBiotech Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 180. RayBiotech Recent Development
Table 181. Beijing Solarbio Science & Technology Company Details
Table 182. Beijing Solarbio Science & Technology Business Overview
Table 183. Beijing Solarbio Science & Technology Anti-CD47 Antibody Product
Table 184. Beijing Solarbio Science & Technology Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 185. Beijing Solarbio Science & Technology Recent Development
Table 186. Bethyl Laboratories Company Details
Table 187. Bethyl Laboratories Business Overview
Table 188. Bethyl Laboratories Anti-CD47 Antibody Product
Table 189. Bethyl Laboratories Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 190. Bethyl Laboratories Recent Development
Table 191. Abeomics Company Details
Table 192. Abeomics Business Overview
Table 193. Abeomics Anti-CD47 Antibody Product
Table 194. Abeomics Revenue in Anti-CD47 Antibody Business (2020-2025) & (US$ Million)
Table 195. Abeomics Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
Table 199. Authors List of This Report


List of Figures
Figure 1. Anti-CD47 Antibody Picture
Figure 2. Global Anti-CD47 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-CD47 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibody Features
Figure 5. Polyclonal Antibody Features
Figure 6. Global Anti-CD47 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-CD47 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology Case Studies
Figure 9. Medical Case Studies
Figure 10. University Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-CD47 Antibody Report Years Considered
Figure 13. Global Anti-CD47 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Anti-CD47 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti-CD47 Antibody Market Share by Region: 2024 VS 2031
Figure 16. Global Anti-CD47 Antibody Market Share by Players in 2024
Figure 17. Global Top Anti-CD47 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD47 Antibody as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Anti-CD47 Antibody Revenue in 2024
Figure 19. North America Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Anti-CD47 Antibody Market Share by Country (2020-2031)
Figure 21. United States Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti-CD47 Antibody Market Share by Country (2020-2031)
Figure 25. Germany Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti-CD47 Antibody Market Share by Region (2020-2031)
Figure 33. China Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-CD47 Antibody Market Share by Country (2020-2031)
Figure 41. Mexico Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti-CD47 Antibody Market Share by Country (2020-2031)
Figure 45. Turkey Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Anti-CD47 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. BosterBio Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 49. Leinco Technologies Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 50. Bioss Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 51. Novus Biologicals Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 53. Biorbyt Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 54. Abbexa Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 55. Bio X Cell Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 56. GeneTex Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 57. R&D Systems Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 58. LSBio Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 59. MyBioSource Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 60. ProSci Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 61. antibodies-online Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 62. ABclonal Technology Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 63. Abnova Corporation Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 64. G Biosciences Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 65. BioLegend Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 66. Bio-Rad Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 67. Huabio Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 68. BPS Bioscience Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 69. OriGene Technologies Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 70. St John's Laboratory Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 71. Absolute Antibody Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 72. NSJ Bioreagents Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 73. Cell Signaling Technology Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 74. RayBiotech Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 75. Beijing Solarbio Science & Technology Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 76. Bethyl Laboratories Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 77. Abeomics Revenue Growth Rate in Anti-CD47 Antibody Business (2020-2025)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies